Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Peuskens

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Expert Opinion on Pharmacotherapy|February 5, 2014
Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychoticsAndreas Schreiner, Marjolein Lahaye, Joseph Peuskens, et al.
Annals of General Psychiatry|April 6, 2011
Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and BelgiumTim Lambert, José M Olivares, Joseph Peuskens, et al.
Schizophrenia Research|October 14, 2009
Correlates of cognitive impairment in first episode schizophrenia: the EUFEST studySilvana Galderisi, Michael Davidson, René S Kahn, et al.
Lancet (London, England)|April 1, 2008
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialRené S Kahn, W Wolfgang Fleischhacker, Han Boter, et al.
The American Journal of Psychiatry|April 17, 2009
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)Michael Davidson, Silvana Galderisi, Mark Weiser, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Expert Opinion on Pharmacotherapy|February 5, 2014
Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychoticsAndreas Schreiner, Marjolein Lahaye, Joseph Peuskens, et al.
Annals of General Psychiatry|April 6, 2011
Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and BelgiumTim Lambert, José M Olivares, Joseph Peuskens, et al.
Schizophrenia Research|October 14, 2009
Correlates of cognitive impairment in first episode schizophrenia: the EUFEST studySilvana Galderisi, Michael Davidson, René S Kahn, et al.
Lancet (London, England)|April 1, 2008
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialRené S Kahn, W Wolfgang Fleischhacker, Han Boter, et al.
The American Journal of Psychiatry|April 17, 2009
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)Michael Davidson, Silvana Galderisi, Mark Weiser, et al.
Pageof 8